Adbry® | Adtralza® | BAK1.1 [2
] | CAT-354 [2
] | tralokinumab-ldrm
Tralokinumab is a monoclonal antibody directed against interleukin 13 (IL-13), a cytokine secreted by T helper cells, and which is a central mediator of the physiological changes induced by allergic inflammatory reactions [4
] Binding affinity of tralokinumab was optimised (aka
affinity maturation) using an in vitro
ribosome display technology [2
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.